ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 120 filers reported holding ANTARES PHARMA INC in Q4 2018. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WILLIAM HARRIS INVESTORS INC | 2,338,735 | $6,244,000 | 1.73% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,603,703 | $25,642,000 | 1.03% |
Broadfin Capital, LLC | 6,100,000 | $16,288,000 | 0.80% |
ASHFORD CAPITAL MANAGEMENT INC | 1,088,675 | $2,907,000 | 0.58% |
MARINER INVESTMENT GROUP LLC | 296,477 | $792,000 | 0.15% |
THOMPSON DAVIS & CO., INC. | 36,500 | $97,000 | 0.14% |
Peregrine Asset Advisers, Inc. | 53,034 | $142,000 | 0.13% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,165,738 | $3,101,000 | 0.12% |
Avenir Corp | 341,035 | $911,000 | 0.08% |
Brown Advisory Securities, LLC | 50,550 | $135,000 | 0.05% |